本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Forte BioSciences Inc

31.50
+1.846.20%
成交量:9.96萬
成交額:308.65萬
市值:3.95億
市盈率:-7.17
高:32.00
開:29.46
低:29.25
收:29.66
52周最高:32.00
52周最低:4.90
股本:1,252.69萬
流通股本:926.19萬
量比:1.48
換手率:1.08%
股息:- -
股息率:- -
每股收益(TTM):-4.3909
每股收益(LYR):-12.1671
淨資產收益率:-110.72%
總資產收益率:-58.07%
市淨率:4.69
市盈率(LYR):-2.59

資料載入中...

2022/09/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/24

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/15

重要事件披露

8-K - Current report
2022/08/12

重要事件披露

8-K - Current report
2022/08/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/08/01

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/07/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/12

重要事件披露

8-K - Current report
2022/07/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/05

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/06/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/06/07

重要事件披露

8-K - Current report
2022/06/02

重要事件披露

8-K - Current report
2022/05/24

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/05/16

重要事件披露

8-K - Current report